Leveraging Pharmacists to Expand Vital Access to Contraception for Teens
Editor’s note: The United Nations sustainable development goals identify access to sexual and reproductive health services as a priority under the health and well-being goal. As we just celebrated the International Day of the Girl on October 11, this post explains one way to eliminate a barrier to contraceptive access by allowing pharmacists to prescribe birth control.
One of the key indicators of an adolescent’s health and well-being is their access to sexual and reproductive health services. This is largely because adolescent pregnancy is associated with negative outcomes such as lower educational and economic achievement throughout a mother’s lifetime and higher likelihood of her reliance on social services. Unintended pregnancies disproportionately affect young women under the age of 24, and as many as 90 percent of pregnancies in adolescents ages 15-17 are unintended. One well-established way to address unintended pregnancies is through greater access to birth control.
Since 2013, nine states (Table 1) have passed legislation allowing pharmacists to prescribe certain types of birth control without an initial visit with a health care provider. While some may be concerned about taking the birth control conversation out of the context of a provider visit, research has suggested that women are able to choose which method is best for them and assess their risks just as well, if not better, for themselves through a medical self-screener questionnaire—without direct guidance from a physician. In addition to being safe and effective, researchers estimated that pharmacist-prescribed birth control could prevent up to half of all unintended pregnancies each year, which would equate to approximately $250 billion in public savings annually.
What does this mean for adolescent girls?
Considering many teens don’t regularly visit a primary care provider, and the burden of unintended pregnancy is greatest in the adolescent population, the ability for them to receive contraception through a pharmacist could remove a significant barrier to accessing quality reproductive health services. Of the nine states with laws, at this time, four states clearly exclude adolescents from pharmacist-prescribed birth control, with one state, New Hampshire, yet to implement the law and finalize its regulations. These four states’ laws either do not apply to adolescents or place more restrictions on adolescents seeking contraceptives, even though there is clear evidence that there is no added risk for adolescents to receive birth control from a pharmacist rather than their provider.
Pharmacist-prescribed contraceptives could be a big step forward in eliminating barriers to contraceptive access. However, policymakers must craft and implement these policies in a way that meets the needs of all young women, including—perhaps especially—adolescents given the higher proportion of adolescents with unintended pregnancies and the lifetime impacts that can result. We as public health professionals, policymakers and clinical providers, need to ensure that well-meaning policies intended to increase contraceptive access are inclusive of young women of all ages and enable adolescents to safely receive the reproductive health care that meets their needs.
Table 1: Review of State Policies Allowing Pharmacist-Prescribed Birth Control
State |
Year |
Exclude women <18 years |
Contraceptives covered |
2013 |
No |
The pill, the patch, Depo Provera injection, the vaginal ring |
|
2016 |
Yes |
Oral contraceptives and the patch |
|
2017 |
Yes |
The pill, the patch, Depo Provera injection, the vaginal ring |
|
2017 |
No |
all FDA approved contraceptive medications and self-administered contraceptive devices |
|
2017 |
No |
The pill, the patch, Depo Provera injection, the vaginal ring |
|
2015 |
No, but minor needs evidence of previous prescription from clinician |
The pill and the patch |
|
2016 |
Yes |
The pill and the patch |
|
2016 |
Yes |
The pill and the patch |
|
2018 |
TBD |
The patch, the pills, the vaginal ring |
Ava Skolnik, MPH, is a former clinical researcher coordinator at PolicyLab.